GI Portfolio I/ DE000A0KDYE3 /
NAV5/23/2024 | Chg.+80.5391 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
20,747.2598EUR | +0.39% | reinvestment | Mixed Fund Worldwide | Union Inv. Privatf. ▶ |
GlobeNewswire
3/2/2022
Gastro Care Partners Taps Fujifilm to Deliver Best in Breed Endoscopic Imaging Solutions to GI Pract...
GlobeNewswire
4/18/2018
Gastrointestinal, Laparoscopy and Urology Applications Drive the Demand for Endoscopy Devices to Rea...
GlobeNewswire
3/5/2018
Shire plc : U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic C...
GlobeNewswire
3/5/2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation